From : Averhoff, Francisco (CDC/DDID/NCHHSTP/DVH) <fma0@cdc.gov>
To : David Metreveli <dudametreveli@hotmail.com>; Tengiz Tsertsvadze <tt@aidscenter.ge>; Maia Butsashvili <maiabutsashvili@gmail.com>; Davit Sergeenko (dsergeenko@moh.gov.ge) <dsergeenko@moh.gov.ge>; Gamkrelidze, Amiran (CDC ncdc.ge) <a.gamkrelidze@ncdc.ge>; Tamar Gabunia <tgabunia@moh.gov.ge>; Massimo Colombo <mcolombo46@yahoo.it>; Jeffrey Lazarus <jeffrey.lazarus@isglobal.org>; Stefano Gnes <s.gnes@easl-ilf.org>; Nasrullah, Muazzam (CDC/DDID/NCHHSTP/DVH) <hij9@cdc.gov>; Margaret Hellard <margaret.hellard@burnet.edu.au>
Subject : EDITORIAL----- Georgia CoE for_JHep
Cc : Tinatin Kuchuloria <kuchuloria.tatia@gmail.com>; akaki abutidze <akakiabutidze@yahoo.com>
Received On : 14.06.2019 18:43

Dear co-authors,

 

I hope you are all well.  As we drafted the commentary, we realized the important contributions of you all, and thought best to expand the authorship line.  That said, I would like to advise that the journal “may” ask for a reduction in number of authors.  If that is the case, we may have to reduce the author list, I hope not, or do I anticipate, however, I did want to make you aware.  The original author line up included only MOH, NCDC, EILF and CDC.  Or, the commentary may not be accepted.  

 

Muazzam will share a cleaned/revised version for submission, as time is short.

 

Best regards, FA

 

Francisco Averhoff MD, MPH

CAPT US Public Health Service

Associate Director for Global Health

Division of Viral Hepatitis

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

Centers for Disease Control and Prevention

1600 Clifton Road, MS G-37

Atlanta, GA 30333

phone: 404-718-8501

fax: 404-718-8588

e-mail: fma0@cdc.gov